Co-inhibitory receptors

Show results for

Unknown (582)
Transcriptomics (118)
Genomics (99)
Proteomics (12)
Other (4)
Metabolomics (1)

Organisms

Homo sapiens (64)
Mus musculus (53)
Schizophyllum commune H4-8 (6)
Mycobacterium tuberculosis SP7 (6)
Oryza sativa Japonica Group (6)
Eriocheir sinensis (6)
Candidatus Endoriftia persephonae (6)
Mycobacterium tuberculosis SP10 (6)
Mycobacterium tuberculosis SP13 (6)
Mycobacterium tuberculosis SP22 (6)
Enterobacter ludwigii (6)
Chlamydomonas reinhardtii (6)
Lama (6)
Pyricularia oryzae P131 (6)
Enterococcus mundtii CRL35 (6)
Pongo pygmaeus (6)
Oncorhynchus tshawytscha (6)
Pseudomonas canadensis (6)
Strongylocentrotus purpuratus (6)
Influenza A virus (A/California/04/2009(H1N1)) (6)
Salmonella enterica subsp. enterica serovar Typhimurium (6)
Homo (6)
Rattus norvegicus (5)
Canis lupus familiaris (3)
Macaca mulatta (2)
Lactococcus lactis (1)
Salmo salar (1)
Bos taurus (1)
Botryllus schlosseri (1)
Danio rerio (1)

Organisms

Homo sapiens (36)
Mus musculus (36)
Canis lupus familiaris (3)
Macaca mulatta (2)
Botryllus schlosseri (1)
Danio rerio (1)

Repository

ENA (92)
geo (75)
biostudies-arrayexpress (52)
pride (6)
MassIVE (3)
EGA (2)
jPOST (2)
iProX (1)
MetaboLights (1)

Tissue

Brain (2)
Cell culture (2)
Monocyte-derived dendritic cell (1)
Neuron of the forebrain (1)
Peripheral blood mononuclear cell (1)
Dendritic cell (1)
Hippocampal neuron (1)
Blood (1)
T cell (1)

Disease

Susceptibility to dengue virus (1)
Dengue shock syndrome (1)
Dengue hemorrhagic fever (1)
Dengue disease (1)

Technology Type

Mass Spectrometry (6)
Bottom-up proteomics (2)
Affinity purification coupled with mass spectrometry proteomics (2)
Shotgun proteomics (2)
Mass spectrometry (1)
Gel-based experiment (1)
Data-dependent acquisition (1)
Data-independent acquisition (1)
SWATH MS (1)

Instrument Platform

Illumina HiSeq 2500 (3)
Illumina NovaSeq 6000 (2)
Q Exactive HF (2)
Illumina HiSeq 3000 (1)
LTQ Orbitrap Velos Pro (1)
Liquid Chromatography MS - positive - reverse-phase (1)
Liquid Chromatography MS - negative - reverse-phase (1)

Publication Date

2024 (17)
2018 (15)
2025 (11)
2026 (10)
2020 (9)
2010 (9)
2023 (9)
2022 (8)
2014 (7)
2015 (6)
2019 (5)
2013 (5)
2011 (5)
2009 (5)
2021 (5)
2008 (4)
2007 (3)
2017 (3)
2016 (2)
2012 (2)

Metabolite Name

[(9S)-8,8-dimethyl-2-oxo-9,10-dihydropyrano[2,3-h]chromen-9-yl] (Z)-2-methylbut-2-enoate (1)
[(3S,6S)-6-[5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)chromenylium-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate (1)
[(2R)-3-Hexadecoxy-2-hydroperoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate (1)
Val-Thr-Ala-Asp-Lys (1)
Val-Leu-Ser-Asp (1)
Val-Glu-Thr-Glu (1)
Val-Asn-Tyr-Val-Asn (1)
Val-Arg-His-Arg (1)
Tyr-Trp-Phe (1)
Tyr-His-Leu (1)
Tyr-Arg-Ile-Glu (1)
Tubocurarine chloride (1)
Trp-Pro-Leu (1)
Trp-Phe-Glu (1)
Trp-Glu-Asp (1)
Thr-Val-Ile-Thr-Gly (1)
Thr-Thr-Asp-Glu-Tyr (1)
Thr-Asp-Phe-Glu (1)
Ser-Glu-Val-Lys-Met (1)
Ser-Glu-Lys-Ile-Asp (1)
Ser-Arg-Lys-Glu-Ser (1)
S-Isopropyl-isothiourea (1)
PtdIns-(4)-P1 (1,2-dihexanoyl) (1)
Pro-Pro-Val (1)
Picolinamidoxime (1)
Phe-Trp-Tyr (1)
Phe-Thr-Glu-Lys (1)
Phe-Phe-Glu-Ser-Phe (1)
Phe-Lys-Thr-Glu (1)
Phe-Ala-Arg-Asp (1)

First Public Date

2024 (13)
2018 (13)
2026 (10)
2022 (10)
2020 (10)
2025 (9)
2023 (7)
2021 (7)
2019 (6)
2017 (3)
2014 (2)
2016 (1)
2015 (1)

Study type

Transcription profiling by array (40)
RNA-seq of coding RNA (6)
ChIP-seq (2)
Transcription profiling by SAGE (1)
Unknown experiment type (1)
ChIP-chip by tiling array (1)
RNA-seq of coding RNA from single cells (1)

Release Date

2022 (74)
2021 (58)
2019 (55)
2020 (51)
2023 (46)
2024 (45)
2018 (41)
2025 (37)
2015 (37)
2017 (36)
2016 (32)
2013 (19)
2010 (18)
2014 (17)
2011 (15)
2012 (14)
2009 (13)
2007 (8)
2008 (7)
2026 (5)
2006 (3)
2005 (1)
2002 (1)
1997 (1)

Lab affiliation

Laboratory of Immunity & Cell Communication, Division BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic (1)
School of Cellular and Molecular Medicine University of Bristol Biomedical Sciences Building University Walk Bristol BS8 1TD, UK (1)
Department of Neuroscience, Tufts University School of Medicine (1)
CNCR,VU Amsterdam (1)
Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, OncoProteomics Laboratory, Amsterdam, Netherlands (1)
Department of Health Sciences and Technology (D-HEST) Institute of Molecular Systems Biology (IMSB) ETH Zürich (1)

Previous page
1 / 82
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 82
Next page

Sort by:

Relevance

Page size

CXCR3+ Treg cells suppress Th1-immune responses through expression of the co-inhibitory receptors CD85k and Lag-3

CD4+Foxp3+ Treg cells are essential for maintaining self-tolerance and preventing excessive immune responses. In the context of Th1 immune responses, co-expression of the Th1 transcription factor T-bet with Foxp3 is essential for Treg cells to control Th1 responses. T-bet-dependent expression of CXC...

ORGANISM(S): Mus musculus

2018-06-30 | E-MTAB-6156 | biostudies-arrayexpress

CXCR3+ Treg cells suppress Th1-immune responses through expression of the co-inhibitory receptors CD85k and Lag-3

PRJEB23252 | ENA

The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity.

Not available

S-EPMC7118128 | biostudies-literature

Human Immunodeficiency Virus Type-1 Elite Controllers Maintain Low Co-Expression of Inhibitory Receptors on CD4+ T Cells.

Not available

S-EPMC5786543 | biostudies-literature

HTLV-1 bZIP Factor Enhances T-Cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors.

Not available